Briacell Therapeutics Corp BCTX

$4.00 -0.02 (-0.50%)

Valuation

Market cap
34,973,000
Revenue TTM
$0
Net income TTM
$-26,310,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
84,500
Avg volume
326,420
Day's range
$3.91 – $4.10
Shares out
8,700,000
Stochastic %K
18%
Beta
1.21
Analysts
Strong Buy
Price target
$40.00

Price

Company profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator...

Show more

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 921 1810
Website
https://briacell.com
Address
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

Latest news

No headlines yet.

Stocktwits

Biotechlineup Oct 7, 8:04 PM
$BCTX we all come here to see if our fellow investors have anything new to share. Well the good news is that no news is the best news. Patience for a mid December read out would be wonderful, if mid January even better. Now that dilution off the table for awhile just sit back and relax. Key word Ample . I’m sure we will get some news on the full 354 enrollment relatively soon and prior to any 144 event news. Key word Hockey stick. IMO a great time to watch the technical pattern and add at support levels.
1 replies
CoffeeRocks Oct 7, 6:16 PM
$BCTX Bria-IMT™ (lead candidate): In an ongoing pivotal Phase 3 trial (Bria-ABC / NCT06072612) for metastatic breast cancer, testing Bria-IMT ± immune checkpoint inhibitor vs. physician’s choice. The combination regimen has FDA Fast Track designation. An independent Data Safety Monitoring Board (DSMB) has repeatedly recommended the trial continue without modifications (most recent public updates in 2026). Overall survival is the primary endpoint, with an interim analysis planned after 144 deaths.  • Bria-BRES+™: FDA cleared the IND in May 2026, allowing initiation of a Phase 1/2a study in metastatic breast cancer. This is a next-generation personalized, off-the-shelf cell-based immunotherapy building on the Bria-OTS platform.  • Bria-PROS+™: FDA cleared the IND in August 2026, enabling a Phase 1/2a study in prostate cancer. It is also a next-generation personalized immunotherapy; the program previously received a $2M NCI grant. 
0 replies
CoffeeRocks Oct 7, 4:51 PM
$CAPR $BCTX $VKTX $SLS $ABCL 50$ all of these 👆
0 replies
Aye_Sir Oct 7, 4:25 PM
$BCTX i have no luck with bios.
2 replies
CoffeeRocks Oct 7, 2:51 PM
$NVAX $VKTX $HIMS $EBS $BCTX Bios undervalued All are BuYs here at these prices each of these should be above 50$
1 replies
CoffeeRocks Oct 7, 2:32 PM
$BCTX $IOVA $VKTX $SLS $ABCL 4$ BCTX this is where you buy 12$ 🎯
0 replies
JediGreen Oct 7, 7:45 AM
$BCTX I just want everyone to know I personally don’t lend out my shares and a matter of fact don’t even have a margin account just because I’m so much of a bull. 🙂
0 replies
JediGreen Oct 7, 7:40 AM
$BCTX Friday websites should be updating on current short positions in stocks. So we should find out how big there position is and judging on the short volume over the last month I’m going to guess over 1 million shares short in this little float stock. I could be off to depending if some of them covered but I don’t think they have. Tick tock phase 3 coming. Bullish baby.
0 replies